|

SAL-0951 tablets 5mg Clinical Trials

1 actively recruiting trial

Also known as: SAL-0951 tablets 5mg group

Pipeline

Phase 2: 1

Top Sponsors

  • Shenzhen Salubris Pharmaceuticals Co., Ltd.1

Indications

  • Anemia1
  • Cancer1

Other1 trial

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.